Dali-on, Rowejene .

HRN: 24-58-11  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2024
AMPICILLIN 1GM (VIAL)
02/17/2024
02/18/2024
IVT
2 Gm
Now Then Q 6h
PROM
Waiting Final Action 
02/18/2024
CEFUROXIME 500MG (TAB)
02/18/2024
03/02/2024
ORAL
500mg
BID
RMLE, With Repair
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: